Sonya Erickson

Partner and Business Department Chair
Full contact info

Experience

Bonum Therapeutics Closes $93 Million Series A Financing

November 15, 2022

Cooley advised Bonum Therapeutics, a biopharmaceutical company focused on creating highly active and less toxic medicines, on its $93 million Series A financing. Partner Sonya Erickson led the Cooley team advising Bonum Therapeutics.

Related contacts

Sonya Erickson
Partner and Business Department Chair, Seattle
Colleen Badgley
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Arlo Sporn
Associate, Seattle

Related Practices & Industries

Route Hits $1.25 Billion Valuation With Series B Round

February 1, 2022

Cooley advised Route, a post-purchase experience platform and package tracking company, on its $200 million Series B financing round, which brings its valuation to $1.25 billion. Lawyers Dave Young, Joseph Kaczorowski, Robert Pollak and Roslyn Akel led the Cooley team advising Route.

Read more

Related contacts

Dave Young
Partner, Los Angeles Santa Monica
Christopher Kimball
Partner, Washington DC
Milson Yu
Partner, Palo Alto
Amy Saldamando
Paralegal Specialist, Los Angeles Santa Monica
Lei Shen
Partner, Chicago
Blake Martell
Partner, San Francisco
Sonya Erickson
Partner and Business Department Chair, Seattle
Charlie Kim
Partner, San Diego
Jeff Goldman
Special Counsel, Palo Alto
Sharon Connaughton
Special Counsel, Washington DC
Kimberly Nguyen
Special Counsel, Reston
Karen Tsai
Special Counsel, Washington DC
Kristin O'Hanlon
Special Counsel, San Francisco
Jessica Girone
Associate, Los Angeles Santa Monica

Related Practices & Industries

Helion Energy Raises $2.2 Billion With Series E Round

November 11, 2021

Cooley advised Helion Energy, a clean energy company committed to creating a new era of plentiful, zero-carbon electricity from fusion, on its $500 million Series E financing round, which also includes an opportunity for an additional $1.7 billion tied to Helion reaching key performance milestones. Lawyers Sonya Erickson, Colleen Badgley, Ashley Brown, Justine Chiu and Jasjit Grewal led the Cooley team advising Helion.

Read more

Related contacts

Sonya Erickson
Partner and Business Department Chair, Seattle
Colleen Badgley
Associate, Seattle
Richard G.S. Lee
Associate, Washington DC
John Sellers
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Eileen Marshall
Partner, Washington DC
Julia Stark
Associate, Seattle
Phoebe Huang
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle

Related Practices & Industries

Virtual Reality Developer Within Agrees to Sell to Meta

November 5, 2021

Cooley advised Within, a Los Angeles-based firm responsible for developing immersive virtual reality fitness app Supernatural, on its agreement to sell to Meta. Partners Anne Lieberman and Dave Young led the Cooley team advising Within.

Read more

Related contacts

Anne Lieberman
Partner, Los Angeles Santa Monica
Dave Young
Partner, Los Angeles Santa Monica
Jacqueline Grise
Partner, Washington DC
Todd Gluth
Partner, San Diego
Alessandra Murata
Partner, Palo Alto
Jamie Leigh
Partner, San Francisco
Sonya Erickson
Partner and Business Department Chair, Seattle
Dee Bansal
Partner, Washington DC
David Navetta
Partner, Colorado
Stacey A. Bradford
Special Counsel, Washington DC
Karen Tsai
Special Counsel, Washington DC
Kristin O'Hanlon
Special Counsel, San Francisco
Nathan Baum
Associate, New York
Cristina DeBiase
Associate, Boston
Andrew Bae
Associate, Washington DC
Lewis Loy
Associate, Los Angeles Santa Monica
Mor Agam
Associate, New York
David Burns
Special Counsel, Washington DC
Kristopher Kleiner
Special Counsel, Colorado
Claire Gibbs
Associate, Washington DC
Ross Eberly
Partner, Los Angeles Santa Monica
Nicollette R. Kirby
Associate, Washington DC
Eileen Leman
Associate, Los Angeles Downtown
Genevieve Lim Urban
Associate, Seattle
Bryan Berman
Special Counsel, Colorado
Chelsea André
Associate, Colorado
Leo Spicer-Phelps
Associate, London
Andrew Epstein
Special Counsel, Seattle

Related Practices & Industries

Eliem Therapeutics – $92 Million IPO

August 10, 2021

Cooley advised Eliem Therapeutics on its $92 million initial public offering of 7,360,000 shares of common stock, which includes the full exercise of the underwriters’ option to purchase additional shares. Eliem Therapeutics, whose securities now trade on the Nasdaq Global Market under the symbol ELYM, is a clinical-stage biotechnology company focused on developing novel therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Partners Alan Hambelton, Sonya Erickson and Stephen Rosen led the Cooley team.

Related contacts

Alan Hambelton
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Stephen Rosen
Partner, London
Julia Stark
Associate, Seattle
Willy Cowles
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle

Related Practices & Industries

View more

Rankings & accolades

Chambers USA: Corporate/M&A – Washington (2020 – 2023)

The Best Lawyers in America, Venture Capital Law (2004 – 2019)

Chambers USA: America's Leading Lawyers for Business (2013 – 2015)

Washington Super Lawyers (2014 – 2016)

Memberships & affiliations

Washington State Bar Association